Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Xeris Biopharma Holdings (XERS) over the last 5 years, with Dec 2024 value amounting to $1.2 million.

  • Xeris Biopharma Holdings' Depreciation & Amortization (CF) rose 10.10% to $338,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 1.41%. This contributed to the annual value of $1.2 million for FY2024, which is 18.20% down from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Depreciation & Amortization (CF) stood at $1.2 million for FY2024, which was down 18.20% from $1.5 million recorded in FY2023.
  • Over the past 5 years, Xeris Biopharma Holdings' Depreciation & Amortization (CF) peaked at $1.5 million during FY2023, and registered a low of $1.2 million during FY2024.
  • Over the past 3 years, Xeris Biopharma Holdings' median Depreciation & Amortization (CF) value was $1.4 million (recorded in 2022), while the average stood at $1.4 million.
  • As far as peak fluctuations go, Xeris Biopharma Holdings' Depreciation & Amortization (CF) increased by 7.14% in 2023, and later decreased by 18.20% in 2024.
  • Xeris Biopharma Holdings' Depreciation & Amortization (CF) (Yearly) stood at $1.5 million in 2020, then dropped by 9.41% to $1.3 million in 2021, then increased by 5.34% to $1.4 million in 2022, then rose by 7.14% to $1.5 million in 2023, then declined by 18.20% to $1.2 million in 2024.